Skip to main navigationSkip to main content
The University of Southampton
Institute for Life Sciences

CES Academic Programme: AstraZeneca Guest Lecturers Event

CES Seminar
Time:
09:00 - 11:00
Date:
24 November 2016
Venue:
Seminar Room LF9, Level F South Academic Block, Southampton General Hospital

For more information regarding this event, please email Corrine Hughes at c/o IfLSAdmin@soton.ac.uk .

Event details

A CES Seminar Series event featuring a double presentation by the Vice-President and Head of the Translational Biology Department at AstraZeneca and the Associate Principal Scientist of the same department.

 

Professor Outi Vaarala's talk: “AZ RIA iMed strategy in respiratory”

Christopher McCrea's talk: “Anti-viral host defense research in respiratory at AstraZeneca”

Related article: Southampton scientists forge strategic partnership with AstraZeneca to study respiratory disease

Speaker information

Professor Outi Vaarala,AstraZeneca, Gothenburg,Outi Vaarala is Vice-President and Head of Translational Biology Department in Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca Gothenburg. Her department is responsible for the biology research from target identification to Ph2 projects including the invention of biomarkers for the personalized treatments. Outi Vaarala is MD and professor of pediatric immunology. Her research is focused to the biological drivers of immune-mediated diseases, such as allergies, asthma and autoimmune diseases. Outi Vaarala has published more than 200 peer-reviewed articles in scientific journals in the field of immunology.

Christopher McCrae,AstraZeneca, Gothenburg,Christopher McCrae is an Associate Principal Scientist in Translational Biology, Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca Gothenburg. Chris is Translational Lead on the inhaled interferon beta-1a programme, currently in Phase 2 development. In addition, Chris conducts research into new targets and mechanisms involved lung host defense in asthma and chronic obstructive pulmonary disease (COPD), and leads several academic collaborations in this area. Chris’s main research interest is in understanding how virus-airway epithelial cell interactions determine risk of asthma or COPD exacerbations.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×